Democratizing hedge fund level analysis tools for everyone
| Name | Kimia Farma Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 03-31-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Bio Farma (Persero) | 89.82 | 89.82 |
| Public < 5% | 10.18 | 10.18 |
| Negara Republik Indonesia | 0.0 | 0.0 |
| Source | 2022 | 2021 |
|---|---|---|
| KAEF | F2 | Retail |
| KAEF | F2 | Distribution |
| KAEF | F2 | Manufacture |
| KAEF | F2 | Other |
| KAEF | F2 | Others |
| Region | 2022 | 2021 |
|---|---|---|
| KAEF | F2 | Indonesia |
| KAEF | F2 | Overseas |
| KAEF | F2 | Others |
| KAEF | F2 | Saudi Arabia |
| KAEF | F2 | Netherlands |
| KAEF | F2 | China |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.31 | # 5 / 15 |
| EV_EBITDA | 28.87 | # 11 / 15 |
| PER | -12.15 | --- / 15 |
| PBV | 0.92 | # 3 / 15 |
| DER | 3.67 | # 12 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -2.565 | --- / 15 |
| ROA % | -1.6099999999999999 | --- / 15 |
| ROE % | -7.61 | --- / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2022 | 32.66 | 3.0 |
| 2021 | 2.54 | 0.2 |
| 2019 | 29.96 | 2.4 |
| Timeframe | Performance |
|---|---|
| 1W % | -5.5 |
| 1Mo % | -8.8 |
| 3Mo % | 3.0 |
| 1Yr % | -13.3 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 16.21 | 56.88 T | 58.14 T | 34,651 B | 5,348 B | 3,508 B |
| SOHO | 30.18 | 17.51 T | 19.64 T | 10,338 B | 711 B | 581 B |
| SIDO | 14.84 | 16.20 T | 15.77 T | 3,639 B | 1,481 B | 1,091 B |
| TSPC | 8.20 | 12.45 T | 10.93 T | 13,512 B | 2,016 B | 1,515 B |
| PYFA | -11.02 | 5.39 T | 11.42 T | 2,747 B | -142 B | -488 B |
| MDLA | 9.50 | 3.67 T | 6.27 T | 14,788 B | 557 B | 386 B |